← Eichor
Condition: Anal Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Anal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT04792892High Resolution Anuscopy Study
Phase N/A · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06697964Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Phase 2 · 1 location(s) · Instituto do Cancer do Estado de São Paulo · NCT06640283Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)
Phase 2 · 15 location(s) · Grupo Espanol Multidisciplinario del Cancer Digestivo · NCT05661188Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma
Phase 2 · 5 location(s) · Centre Hospitalier Universitaire de Besancon · NCT04894370Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
NA · 2 location(s) · University of California, San Francisco · NCT04221893Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714HPV Genotype Attribution and Disease Burden of Anal Cancer in China
Phase N/A · 1 location(s) · Fudan University · NCT06670495Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Phase 2 · 4 location(s) · Dustin Deming · NCT06493019At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860Host Genome Methylation: a Screening Tool in Anal Cancer Detection
NA · 9 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06792604Stigma and Psychological profilE in REctal-anal caNcer pAtients
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06366841Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase
Phase 2 · 1 location(s) · Fudan University · NCT07555678Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
Phase 2 · 1 location(s) · University of Aarhus · NCT05055635A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial
Phase 1 · 12 location(s) · EvolveImmune United, Inc · NCT07217171Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma
NA · 4 location(s) · Umeå University · NCT04462042Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis
NA · 8 location(s) · Universitair Ziekenhuis Brussel · NCT07029152Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06364579Multidimensional Examination of Patients with Colorectal and Anal Cancer
Phase N/A · 2 location(s) · University of Pecs · NCT06562140Implementation of Anal Cancer Screening and Treatment in Nigeria
NA · 1 location(s) · University of Maryland, Baltimore · NCT05817370Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer
Phase N/A · 3 location(s) · Aarhus University Hospital · NCT07296237MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
Phase 2 · 5 location(s) · University Health Network, Toronto · NCT06050707Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
Phase 2 · 1 location(s) · University of Chicago · NCT06669572Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
Phase N/A · 1 location(s) · Herlev Hospital · NCT05438836A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Phase 1/Phase 2 · 8 location(s) · LigaChem Biosciences, Inc. · NCT05941507Deciphering Mechanisms Underlying Cancer Immunogenicity
NA · 3 location(s) · Institut Claudius Regaud · NCT03958240IMRT Versus IMPT With Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer
NA · 1 location(s) · Tata Memorial Centre · NCT06630793
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.